Work

Phase 1B study of vemurafenib in combination with irinotecan and cetuximab in patients with BRAF-mutated advanced cancers and metastatic colorectal cancer.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.3516

Authors: David S. Hong, Van Karlyle Morris, Siqing Fu, Michael J. Overman, Sarina Anne Piha-Paul, Bryan K. Kee, Ralph Zinner, David R. Fogelman, Reena Mistry, Imad Shureiqi, Funda Meric-Bernstam, Scott Kopetz

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2531555720

Cites:

Cited by: 28

Related to: 10